CD79A and myasthenia gravis: The top 1 biomarker candidate, C-C chemokine ligand 28 (CCL28), which recruits primarily IgA-producing B cells, and CCL20 (11th top biomarker), which recruits dendritic and T cells to the sites of inflammation in mucosal tissues, were elevated by about 75% in MG patients.